Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Shares Issued (2016 - 2025)

Corcept Therapeutics' Shares Issued history spans 10 years, with the latest figure at $2.9 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 86.75% year-over-year to $2.9 million; the TTM value through Dec 2025 reached $15.9 million, up 190.69%, while the annual FY2025 figure was $15.9 million, 190.69% up from the prior year.
  • Shares Issued for Q4 2025 was $2.9 million at Corcept Therapeutics, down from $8.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $8.0 million in Q3 2025 and bottomed at -$2.6 million in Q4 2022.
  • The 5-year median for Shares Issued is $1.7 million (2022), against an average of $2.2 million.
  • The largest annual shift saw Shares Issued surged 741.25% in 2021 before it plummeted 185.53% in 2022.
  • A 5-year view of Shares Issued shows it stood at $3.0 million in 2021, then tumbled by 185.53% to -$2.6 million in 2022, then skyrocketed by 133.58% to $875000.0 in 2023, then surged by 75.09% to $1.5 million in 2024, then surged by 86.75% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for CORT's Shares Issued are $2.9 million (Q4 2025), $8.0 million (Q3 2025), and $3.2 million (Q2 2025).